Pharma Industry News

HPV vaccine to thank for 89% decline in cervical cancer

The authors of the study also highlighted a “herd immunity” benefit, as a drop in disease among unvaccinated women was observed.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]